ArticleArchives of gynecology and obstetrics2013

Usefulness of the HE4 biomarker as a second-line test in the assessment of suspicious ovarian tumors.

Rafal Moszynski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.